UUID:17F65627- FZGB- 4DAC- 864E- AASBAGBRCEelBFa
RO- 91A- PR

||lllllllll||||l|||||||||||IllIll|I||||||||Il||||I||||||||||I||
Ill Illlllllllllllllllllllllllllllllllllllllllllllll ,
iilliiilllllllllillllllllll|IllllllllllllllllllIllllllllllll l||l| ,

Clinical Case Report moo-:5
(For Collection of Cancerous Tissue)

 

 

informed Consenﬁ W “5‘3 l ”l

I personally informed this patient that a specimen(s) would be collected to be used for research

purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT 417]”!
FORM with the patient and answered any questions the patient had. The patient then signed the 4f»)
consent form as a free and voluntary act A copy of this informed consent document will be retained at

our institution.”

. «me or Physician or Study Coordinator , mgnature Date

 

ICTinical Information]

 

. . , , . ,. . RMA’I'ION.’ ' .
Birth H ' Marital 1'
Cl Single

Gender ' i ' ' I C! Divorced El Widow Blood Pressure Heart Rate
[3 Female

 

 

' HISTORY: OFPRESENT ILLNESS ' , 1 "
ChiefComplainls: TMLM Wad/ﬂowing. ) Panaxj‘mﬂ

Symptoms: \M elf-WW Ease

Clinical Findings:

 

 

 

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic I: 80-90 Symptomatic but Fully Ambulatory CI 60-70 Symptomatic, in bed less than 50% of day
)940-50 Symptomatic, in bed more than 50% of day but not bed ridden :1 20-30 Bed Ridden
1

 

 

 

. ZMEDICATIO
Route

 

PAST MEDICAL HISTORY . ,

Date

 

Status

Treatment

 

 

 

 

. . . . TIOBIGY'N’IIISTORY ., ., , , . .
Menopausal Status Date of First Menses # of Pregnancies
El Pre-menopausal
1:1 Peri-Menopausal Date of Last Menses # of Live Births
El Post-menopausal

 

 

 

Birth Control: :1 Condom [:1 Oral Contraceptive D IUD

 

 

El Other:

1: Hormone Replacement
Therapy:

 

:SOCIAL'HISTO Y '-

Environmental Hazards:

Status

El YES NO

Alcohol Consum

Status Drinks

YES El NO

TYPE

Use
Current Status

Duration

Duration

&

Duration

Cl YES NO

Relative

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test Result I Date T .1 Test Result Date
HIV Megative El Positive: ’ CEA El Negative El Positive:

Hep B @Negaiive El Positive: CA 15-3 El Negative D Positive:

Hep C ‘lz’Negative El Positive: : I CA 19-9 El Negative El Positive:
AFP in Negative U Positive: PSA :1 Negative E] Positive:

- Other: . . .
Other. El Negative El Positive: 1:! Negative E] Posmve:
BIT Cell Markers:

 

 

 

 

 

 

 

 

DIAGNOSTIC" STUDIES”

Results
Ultrasound

X-Ra
CT

MRI
Bi

' CLINICALDIAGN
Clinical

Location of Involved L Location of Distant Metastasis

Clinical Date of
T 2 N M Stage:

 

 

[Treatment Information]

Procedure Date of Procedure

Tumor
Detailed Location

1!

Extension of

L Nodes

Location of L Nodes # of L Nodes
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes

Distant Metastasis
Detailed Location

NEOADJUVENT ' I 7 H . ' ‘ i " " or-Moiecul'ar
Dose Date
To
To
To
To
To

 

 

 

 

Consolidated Part-ohm" Diagnosis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Histological DiagnosiswmmmadmL

 

 

, p .. 1, V. _ .,,._;,;.2;Histrilo‘ real-.raﬂW” . rs: _ ,
Cell Distribution + - Structural Pattern -
Diffuse Streaming
Mosaic Storiform
Necrosis Fibrosis
Lymphocytic Inﬁltration PalisagL
Vascular Invasion cystic Degeneration
Clusterized Bleeding
Alveolar Formation Myxoid Change
Indian File Psammoma/Calciﬁcation
‘ _ .f _ __ - -Cﬁej,llulahnifféreiitiation 1' '. . . r .. . _
Squamous + Adenomatous + - Sarcomatous + Lymphomatious + -
Squamoid Cell Glandular cell Round Cell Large Cell
5 indle Cell Cell Stratiﬁcation Fibroblast Small Cell
Keratin Secretion Osteoblast RS Cell/RS Like
Desmosome Intracyt. Vacuole Lipoblast Inﬂam. Cell
Pearl Gland formation Myoblast Plasma Cell
Cellular Differentiation: in Well :1 Moderate :1 Poor
‘ _ . . . _ .NlldearrAppeara‘riCe ,_ .. ‘ 1, .. ' _ , _
Nuclear Atypia: D I II III
Aniso Nucleosis
Hyperchromatism 9i
Nucleolar Prominent V
Multinucleated Giant Cell of
Mitotic Activity j a?
Nuclear Grade: K
[ﬁnal PathMRepoW

 

 

Comments:

 

 

 

Director, Research Pathology

INTEGRATED REPORT OF FINDINGS BY COLLABORATORS AND

‘ PATHOLOGISI'S - I

Date

Prior

Revlewer

 

 

 

 

